HIM
ASMB icon

Hillsdale Investment Management’s Assembly Biosciences ASMB Stock Holding History

Hillsdale Investment Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,142
Closed -$620K – 584
2020
Q3 		$620K Buy
+3,142
New +$791K 0.06% 279
2018
Q2 		– Sell
-158
Closed -$93K – 496
2018
Q1 		$93K Buy
158
+33
+26% +$20.5K 0.01% 290
2017
Q4 		$68K Buy
+125
New +$56.6K 0.01% 303

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Hillsdale Investment Management's ASMB Position: Q4 2020 in Review

Hillsdale Investment Management sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 3,142 shares — an estimated $620K sold.

Hillsdale Investment Management first reported a position in ASMB in Q4 2017 and held it in 3 quarters. The position peaked at $620K in Q3 2020. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Hillsdale Investment Management reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • Hillsdale Investment Management sold 3,142 Assembly Biosciences shares in Q4 2020, an estimated $620K.
  • Hillsdale Investment Management first reported a position in Assembly Biosciences in Q4 2017 and held it in 3 quarters.
  • Hillsdale Investment Management's Assembly Biosciences position peaked at $620K in Q3 2020.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Hillsdale Investment Management's 13F filing for Q4 2020, filed 9 Feb 2021.